EZH2 and gastric cancer: In a recent study, the authors showed that lncRNA UCA1 promoted the cisplatin resistance of MKN45 and MGC803 gastric cancer cells by recruiting EZH2, activating the PI3K/AKT pathway, and inhibiting cisplatin-induced apoptosis [81].